Efficacy News and Research

RSS

G-tube placement not needed for patients with advanced dementia or other near end-of-life conditions

Based on current scientific literature, gastrostomy tube (G-tube) placement or other long-term enteral access devices should be withheld or withdrawn in patients with advanced dementia or other near end-of-life conditions, according to a special report published today in the OnlineFirst version of Nutrition in Clinical Practice, the official journal of the American Society for Parenteral and Enteral Nutrition.

8 Oct 2014

Two randomized trials examine new vaccination strategies for avian influenza

Two randomized trials in the October 8 issue of JAMA examine new vaccination strategies for the prevention and control of avian influenza, often referred to as "bird flu." This is a theme issue on infectious disease.

8 Oct 2014

GeneSolve to license its health optimization system to highly qualified doctors

GeneSolve announced today that it will begin licensing its proprietary health optimization system to a network of highly qualified doctors nationwide.

7 Oct 2014

Cardiac Dimensions adds $8.5M to its previously announced financing

Cardiac Dimensions® today announced the addition of $8.5 million to its previously announced financing.

7 Oct 2014

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announced today the initiation of the pivotal Phase 3 trial (OPUS) in Germany for a rare form of bile duct cancer for which there is currently no acceptable therapy.

7 Oct 2014

Study: Vaccines targeting adults, teens could potentially eliminate TB by 2050

Targets to eliminate tuberculosis (TB) by 2050 are more likely to be met if new vaccines are developed for adults and adolescents instead of for infants, according to new research published in the journal Proceedings of the National Academy of Sciences.

7 Oct 2014

Researchers launch landmark new program to explore potential impact of medical marijuana

Thanks to a $500,000 gift from international best-selling author and mental health advocate Patricia Cornwell, McLean Hospital and Harvard Medical School researchers will launch a landmark new program that will more fully explore the potential impact of medical marijuana on cognition, brain structure and function.

7 Oct 2014

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

The international research & development (R&D) consortium, AfriCoLeish, formed by six research organizations from East Africa and Europe, has launched a Phase III clinical study to address the extreme difficulty in treating visceral leishmaniasis (VL) in patients who also are HIV-positive.

6 Oct 2014

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

Eli Lilly and Company announced today it will discontinue development of tabalumab -- being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) -- due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.

3 Oct 2014

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

Eli Lilly and Company today announced that the European Commission has granted marketing authorisation for Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml) for the treatment of diabetes in adults.

3 Oct 2014

BIDMC receives $20 million grant to evaluate, test monoclonal antibodies for HIV treatment

Beth Israel Deaconess Medical Center has received a four-year, $20 million grant from the Bill & Melinda Gates Foundation to evaluate and test broadly neutralizing monoclonal antibodies for the treatment of HIV.

3 Oct 2014

NKT Therapeutics' NKTT120 receives FDA Fast Track designation for treatment of sickle cell disease

NKT Therapeutics today announced that the U.S. Food and Drug Administration has granted Fast Track designation to NKTT120, the company's lead therapeutic being developed for the treatment of sickle cell disease.

3 Oct 2014

Placenta-derived cells are safe for MS patients

Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders.

1 Oct 2014

Ardelyx announces positive Phase 2b results for tenapanor in IBS-C patients

Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b clinical trial evaluating tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C).

1 Oct 2014

Bionic Vision Australia reports positive results of prototype implant in patients with RP-induced vision loss

Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial of its prototype 24-channel percutaneous implant in patients with profound vision loss from the eye disease retinitis pigmentosa (RP).

1 Oct 2014

M.E.D. Surgical to market GBUK’s products across Republic of Ireland, Northern Ireland

GBUK Ltd has announced that it has agreed an exclusive distribution deal which will see M.E.D. Surgical represent the company across the Republic of Ireland and Northern Ireland.

1 Oct 2014

Endo resolves claims relating to vaginal mesh products

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that it has reached master settlement agreements with several of the remaining leading plaintiffs' law firms to resolve claims relating to vaginal mesh products sold by Endo's AMS subsidiary.

1 Oct 2014

Research shows resveratrol in grapes inhibits bacteria that cause acne

Got grapes? UCLA researchers have demonstrated how resveratrol, an antioxidant derived from grapes and found in wine, works to inhibit growth of the bacteria that causes acne.

1 Oct 2014

Dandrit Biotech A/S Signs Agreement To Commence Clinical Trials Of Melcancervac®

DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.

30 Sep 2014

Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did not respond to intranasal corticosteroids.

30 Sep 2014

Efficacy News and Research

G-tube placement not needed for patients with advanced dementia or other near end-of-life conditions

Two randomized trials examine new vaccination strategies for avian influenza

GeneSolve to license its health optimization system to highly qualified doctors

Cardiac Dimensions adds $8.5M to its previously announced financing

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Study: Vaccines targeting adults, teens could potentially eliminate TB by 2050

Researchers launch landmark new program to explore potential impact of medical marijuana

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

BIDMC receives $20 million grant to evaluate, test monoclonal antibodies for HIV treatment

NKT Therapeutics' NKTT120 receives FDA Fast Track designation for treatment of sickle cell disease

Placenta-derived cells are safe for MS patients

Ardelyx announces positive Phase 2b results for tenapanor in IBS-C patients

Bionic Vision Australia reports positive results of prototype implant in patients with RP-induced vision loss

M.E.D. Surgical to market GBUK’s products across Republic of Ireland, Northern Ireland

Endo resolves claims relating to vaginal mesh products

Research shows resveratrol in grapes inhibits bacteria that cause acne

Dandrit Biotech A/S Signs Agreement To Commence Clinical Trials Of Melcancervac®

Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News